论文部分内容阅读
选取2014年2月~2015年2月在我院接受治疗的74例肝硬化上合并消化道出血患者,根据治疗方法的不同将患者随机分为对照组和治疗组进行对照组研究,观察并比较奥曲肽与凝血酶联合奥曲肽治疗的临床效果。治疗组的治疗总有效率显著高于对照组,止血时间、住院时间均显著短于对照组,48h再出血率显著低于对照组,差异显著,治疗有统计学意义(P<0.05)。凝血酶联合奥曲肽治疗肝硬化合并上消化道出血的具有十分显著的临床效果,并且能够显著缩短出血时间以及降低再出血的发生率,值得推广应用。
Choose 74 patients with cirrhosis complicated with gastrointestinal bleeding treated in our hospital from February 2014 to February 2015. According to the different treatment methods, the patients were randomly divided into control group and treatment group to study the control group, observe and compare Clinical effect of octreotide combined with thrombin in the treatment of octreotide. The total effective rate of the treatment group was significantly higher than that of the control group, and the bleeding time and hospitalization time were significantly shorter than those of the control group. The rebleeding rate at 48h was significantly lower than that of the control group. The difference was significant (P <0.05). Thrombin combined with octreotide in the treatment of cirrhosis with upper gastrointestinal bleeding has a very significant clinical effect, and can significantly reduce the bleeding time and reduce the incidence of rebleeding, it is worth promoting the application.